Idexx Laboratories IDXX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.14B+4.6% | $1.09B-1.3% | $1.11B-0.4% | $1.11B+11.1% | $998.43M+4.6% | ||
| $418.08M-3.3% | $432.47M+2.5% | $421.89M+1.7% | $414.73M+10.6% | $375.05M-2.2% | ||
| $722.74M+9.8% | $658.11M-3.7% | $683.35M-1.6% | $694.73M+11.4% | $623.38M+9.2% | ||
| 63.4%+3.0pp | 60.3%-1.5pp | 61.8%-0.8pp | 62.6%+0.2pp | 62.4%+2.6pp | ||
| $65.79M-1.6% | $66.83M+5.4% | $63.42M+2.5% | $61.9M+4.8% | $59.06M+2.3% | ||
| $175.25M+4.9% | $167.06M+5.0% | $159.16M-1.2% | $161.11M+3.1% | $156.22M+4.1% | ||
| $119.12M+9.7% | $108.62M+2.5% | $105.94M+7.4% | $98.68M+7.8% | $91.56M-9.5% | ||
| $360.15M+5.2% | $342.51M+4.3% | $328.51M+2.1% | $321.69M+4.8% | $306.85M-0.7% | ||
| $360.15M+5.2% | $342.51M+4.3% | $328.51M+2.1% | $321.69M+4.8% | $306.85M-0.7% | ||
| $362.59M+14.9% | $315.61M-11.1% | $354.85M-4.9% | $373.05M+17.9% | $316.53M+21.0% | ||
| 31.8%+2.8pp | 28.9%-3.2pp | 32.1%-1.5pp | 33.6%+1.9pp | 31.7%+4.3pp | ||
| $7.74M-16.0% | $9.21M-13.6% | $10.66M-5.9% | $11.32M+47.7% | $7.67M+2.2% | ||
| $597K+1.7% | $587K+1.2% | $580K-7.5% | $627K-48.4% | $1.22M-44.7% | ||
| $355.44M+15.8% | $306.98M-11.0% | $344.77M-4.9% | $362.35M+16.9% | $310.08M+20.9% | ||
| $77M+31.0% | $58.79M-16.2% | $70.16M+2.6% | $68.36M+1.4% | $67.41M+67.5% | ||
| $278.45M+12.2% | $248.19M-9.6% | $274.61M-6.6% | $293.99M+21.1% | $242.68M+12.3% | ||
| 24.4%+1.7pp | 22.8%-2.1pp | 24.8%-1.7pp | 26.5%+2.2pp | 24.3%+1.7pp | ||
| $3.47+12.3% | $3.09-9.1% | $3.40-6.3% | $3.63+22.6% | $2.96+13.0% | ||
| $3.50+12.5% | $3.11-9.3% | $3.43-6.3% | $3.66+22.8% | $2.98+12.5% | ||
| 80.2M-1.1% | 81M+0.4% | 80.7M-0.4% | 81M-1.1% | 81.9M-1.6% | ||
| 79.6M-1.0% | 80.4M+0.4% | 80.1M-0.4% | 80.4M-1.1% | 81.3M-1.4% | ||
| $597K+1.7% | $587K+1.2% | $580K-7.5% | $627K-48.4% | $1.22M-44.7% | ||
| $1.14B+4.6% | $1.09B-1.3% | $1.11B-0.4% | $1.11B+11.1% | $998.43M+4.6% | ||
| $400.27M+13.0% | $354.33M-9.5% | $391.47M-4.2% | $408.82M+16.6% | $350.6M+18.7% | ||
| 35.1%+2.6pp | 32.5%-2.9pp | 35.4%-1.4pp | 36.8%+1.7pp | 35.1%+4.2pp | ||
| $362.59M+14.9% | $315.61M-11.1% | $354.85M-4.9% | $373.05M+17.9% | $316.53M+21.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Idexx Laboratories's revenue?
- Idexx Laboratories (IDXX) generated $4.4B in revenue over the trailing twelve months, up 13.1% year over year.
- Is Idexx Laboratories profitable?
- Idexx Laboratories reported $1.1B in net income over the trailing twelve months, a 24.6% net margin.
- What are Idexx Laboratories's profit margins?
- Gross margin is 62.1% and operating margin is 31.6%, with a 24.6% net margin.
- What is Idexx Laboratories's earnings per share?
- Idexx Laboratories's diluted EPS over the trailing twelve months is $13.59.
- Where does Idexx Laboratories's income statement data come from?
- Every line is extracted from Idexx Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
